Tag: NORD conference | Rare Disease Dialog Blog

Connect with NORD

Oct. 23, 2012

TOPIC: Advocacy, Featured News, Industry, Medical, Patients & Members, Research

Rare Disease Regulatory Pathway is Becoming the New Norm

Posted at October 23, 2012 2:11 pm by Mary Dunkle

The regulatory pathway that we have learned from rare diseases is now becoming the paradigm in general, FDA Deputy Commissioner Stephen P. Spielberg, MD, PhD, said this morning in the opening session of Day 2 of the U.S. Conference on Rare Diseases and Orphan Products.

Twitter: RareDiseases

New #raredisease blog: The best part of my job now live! By Program Manager, Alexandra Freitas! http://t.co/5f8HWZFE2t about 4 hours ago
There are nearly 7,000 #rarediseases, of which only about 350 have FDA-approved treatments, affecting nearly 30 million Americans. 02:42:05 PM May 20, 2013
A #raredisease is any disease affecting fewer than 200,000 Americans. 02:41:34 PM May 20, 2013
May is Ehlers-Danlos Syndrome (EDS) Awareness Month! @NadiaBodkin @EDS_Today #raredisease 02:39:17 PM May 20, 2013
Attend the 2013 Smith-Lemli-Opitz Family and Medical Conference! http://t.co/vcxV3mjRp2 02:37:56 PM May 20, 2013

@RareDiseases

Contact NORD	Featured Partnerships	Translate This page:
SUBSCRIBE TO OUR E-NEWS

	PATIENTS & MEMBERS
	RESEARCH
	ADVOCACY
	INDUSTRY
	MEDICAL
	FEATURED NEWS